| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And COO
1 company
Marriott Tina is a President And COO at RECURSION PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $1.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 24, 2024 | RXRX Recursion Pharmaceuticals, Inc. | President And COO | Sale+OE | 6,000 | $6.31 | $37,854.60 | -1.1% | +17.8% | -5.0% | |
| Sep 26, 2024 | RXRX Recursion Pharmaceuticals, Inc. | President And COO | Sale+OE | 6,000 | $7.00 | $42,004.80 | -1.1% | +6.8% | -34.2% | |
| Aug 29, 2024 | RXRX Recursion Pharmaceuticals, Inc. | President And COO | Sale+OE | 6,000 | $7.56 | $45,376.20 | -1.1% | -13.9% | -36.6% | |
| Jul 25, 2024 | RXRX Recursion Pharmaceuticals, Inc. | President And COO | Sale+OE | 6,000 | $8.13 | $48,809.40 | -1.1% | -21.4% | -19.4% | |
| Jun 27, 2024 | RXRX Recursion Pharmaceuticals, Inc. | President And COO | Sale+OE | 6,000 | $7.22 | $43,290.00 | -1.1% | -9.0% | -33.6% | |
| May 30, 2024 | RXRX Recursion Pharmaceuticals, Inc. | President And COO | Sale+OE | 3,000 | $8.78 | $26,325.00 | -0.6% | -16.9% | -52.9% | |
| Apr 25, 2024 | RXRX Recursion Pharmaceuticals, Inc. | President And COO | Sale+OE | 3,000 | $7.67 | $23,020.50 | -0.5% | -0.4% | -26.9% | |
| Mar 21, 2024 | RXRX Recursion Pharmaceuticals, Inc. | President And COO | Sale+OE | 8,000 | $10.75 | $85,979.89 | -0.6% | -14.1% | -37.3% | |
| Feb 22, 2024 | RXRX Recursion Pharmaceuticals, Inc. | President And COO | Sale+OE | 8,000 | $14.90 | $119,160.00 | -1.2% | -37.6% | -38.1% | |
| Jan 25, 2024 | RXRX Recursion Pharmaceuticals, Inc. | President And COO | Sale+OE | 8,000 | $10.35 | $82,761.60 | -1.9% | -22.4% | -28.3% |